Why did Nvidia resume AI chip sales to China?
How are Trump's tariffs impacting US inflation?
What caused JPMorgan’s profit to fall despite beat?
Why are crypto bills stalling in the House?
How will Apple’s rare-earth deal affect supply chains?
What’s behind Tesla’s North American sales leadership exit?
How did BlackRock’s big client redemption affect shares?
AngioDynamics 'Exceptionally Well-Positioned' For 2026, CEO Says: But Tariffs Still Sting
benzinga.com/markets/earnings/25/07/46422835/angiodynamics-exceptionally-well-positioned-2026-ceo-tariffs
AngioDynamics Inc. (NASDAQ: ANGO) on Tuesday posted a fourth-quarter 2025 adjusted loss of 3 cents per share, compared to the consensus for a per-share loss of 12 cents.
Vascular system-focused medical device maker reported sales of $80.2 million, up 12.7% year over year, beating the…
This story appeared on benzinga.com, 2025-07-15 15:59:42.